Saratoga Aggressive Balanced Allc I holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Saratoga Aggressive Balanced Allocation Portfolio Class I SABIX
- NAV / 1-Day Return $12.53 / −0.32 %
- Fund Size $1.8M
- Adjusted Expense Ratio 2.280%
- Net Expense Ratio 0.990%
- Fee Level: Distribution High
- Share Class Type Institutional
- Morningstar Category Moderately Aggressive Allocation
- Equity Style Box (Funds) Mid Blend
- Fixed-Income Style Box (Funds) Medium/Moderate
- Investment Status Open
- TTM Yield 2.25%
- Turnover Ratio 3%
Morningstar’s Analysis SABIX
Will SABIX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 92.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Saratoga Large Capitalization Growth I | 16.03 | 299,551 | — |
Vanguard Interm-Term Bond Index Adm | 14.80 | 276,547 | — |
Saratoga Large Capitalization Value I | 13.57 | 253,598 | — |
Saratoga Mid Capitalization I | 12.83 | 239,821 | — |
Saratoga Small Capitalization I | 10.22 | 190,951 | — |
Vanguard Total Intl Stock Index Admiral | 8.59 | 160,585 | — |
BNY Dreyfus Instl Pref Govt MMkt Instl | 7.53 | 140,662 | Cash and Equivalents |
Saratoga Technology & Comm I | 6.91 | 129,225 | — |
Eaton Vance Glbl Macr Absolute Return I | 3.92 | 73,275 | — |
Saratoga Health & Biotechnology I | 3.76 | 70,252 | — |